The Impact of the COVID-19 Pandemic on Skin Cancers treated with Mohs Micrographic Surgery: A Retrospective Analysis at a Single United States Academic Institution

Main Article Content

Laila Abbas
Jennifer Wang
Rajiv Nijhawan
Divya Srivastava


COVID-19, pandemic, outcomes, Mohs Micrographic surgery


Abstract not available.


1. Nolan GS, Dunne JA, Kiely AL, et al. The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons. BJS (British Journal of Surgery). 2020;107(12):e598-e600.

2. Geskin LJ, Trager MH, Aasi SZ, et al. Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic. J Am Acad Dermatol. 2020;83(1):295-296.

3. Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB. Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic. Br J Dermatol. 2020;183(4):792-794.

4. Andrew TW, Alrawi M, Lovat P. Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic. Clin Exp Dermatol. 2021;46(1):145-146.

5. Capitelli-McMahon H, Hurley A, Pinder R, Matteucci P, Totty J. Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2020:S1748-6815(1720)30539-30538.